85804016

Information

• Trademark
• 85804016

• Source

• Serial Number

  85804016

• Registration Number

  4813223

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 35 - Advertising
  • 42 - Scientific and technological services and research and design relating thereto
  • 45 - Legal services

• Filing Date

  December 17, 2012
  11 years ago

• Registration Date

  September 15, 2015
  9 years ago

• Transaction Date

  September 15, 2024
  2 months ago

• Status Date

  December 15, 2021
  2 years ago

• Published for Opposition Date

  April 22, 2014
  10 years ago

• Location Date

  December 15, 2021
  2 years ago

• First Use Anywhere Date

  January 01, 2002
  22 years ago

• First Use In Commerce Date

  January 01, 2002
  22 years ago

• Status Code

  702

• Current Location

  TMEG LAW OFFICE 107

  Employee Name

  DINALLO, KEVIN

• Attorney Docket Number

  125508/9

  Attorney Name

  Thomas W. Brooke

  Law Office Assigned Location Code

  L70

• Owners

  • SYNBIAS PHARMA AG

Case File Statements

• DM0000: The mark consists of an abstract drawing featuring four dark rectangles of various sizes around a light rectangle. One dark rectangle is inside the light area.
• GS0051: Pharmaceutical and veterinary preparations for treating various types of cancers, diseases of the immunological system, namely, auto-immune diseases, and for prevention of organ rejection after transplantation; chemical preparations for pharmaceutical use, namely, for treating cancer and oncology diseases; chemical reagents for medical or veterinary use; pharmaceutical preparations for medical use for treating mainly cancer and oncology diseases; pharmaceutical preparations for use in chemotherapy; antibiotics
• CC0000: Color is not claimed as a feature of the mark.
• GS0351: Advertising, business management; business administration, business development; marketing services; office functions; regulatory submission management services, namely, assisting others in the preparation and deposit of regulatory documents in the field of veterinary and pharmaceutical preparations
• GS0011: Industrial chemicals; active chemical ingredients for use in the manufacture of chemotherapeutic medicines; active chemical ingredients for use in the manufacture of medicines for treating a wide range of cancers, including hematological malignancies, many types of carcinoma, and soft tissue sarcomas, breast and ovarian cancer, gastric cancer, lung cancer and lymphomas, acute myeloid leukemia, bladder cancer, metastatic breast cancer, metastatic breast cancer, acute myeloid leukemia, and non-Hodgkin's lymphoblastic leukaemia, breast cancer and non-small cell lung cancer, ovarian cancer and lung cancer, colon cancer, in particular, in combination with other chemotherapy, hairy cell leukemia (HCL) and multiple sclerosis, hematological malignancies, T-cell acute lymphoblastic leukemia, relapsed or refractory acute lymphoblastic leukaemia (ALL) in children after at least two other types of treatment have failed, acute myeloid leukaemia (AML) and juvenile myelomonocytic leukaemia (JMML), myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML), immunosuppressant to prevent rejection in organ transplantation, it is especially useful in kidney transplants, to prevent rejection of organ transplants and treatment of renal cell cancer and other tumors, aggressive metastatic or locally advanced breast cancer, multiple myeloma, hematological disorders known as myelodysplastic syndromes (MDS), chronic lymphocytic leukemia, lymphomas and sarcoma, hormone-regractory prostate cancer, lymphoma and multiple myeloma, diseases of the immunological system, namely, auto-immune diseases, and prevention of organ rejection after transplantation; chemical preparations for use as intermediates for manufacture of finished active pharmaceutical ingredients for treating a wide range of cancers, diseases of the immunological system, namely, auto-immune diseases, and prevention of organ rejection after transplantation
• GS0451: Legal services, namely, preparation and deposit for others of regulatory documents in the fields of veterinary and pharmaceutical preparations; patent search services for others
• GS0421: Scientific and technological services, namely, research and design in the field of chemicals, active pharmaceutical ingredients and pharmaceutical finished products and medicines; industrial analysis and research services in the field of chemicals, active pharmaceutical ingredients and pharmaceutical finished products and medicines; development of pharmaceutical preparations and medicines; research in the field of development and testing of pharmaceutical preparations

Case File Event Statements

• 4/2/2013 - 11 years ago

  9 - PRIORITY ACTION E-MAILED Type: GPRA

• 12/20/2012 - 11 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 1/4/2013 - 11 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/5/2013 - 11 years ago

  3 - NOTICE OF DESIGN SEARCH CODE MAILED Type: MDSC

• 1/31/2013 - 11 years ago

  4 - PAPER RECEIVED Type: MAIL

• 2/5/2013 - 11 years ago

  5 - ASSIGNED TO LIE Type: ALIE

• 2/9/2013 - 11 years ago

  6 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 4/1/2013 - 11 years ago

  7 - ASSIGNED TO EXAMINER Type: DOCK

• 4/2/2013 - 11 years ago

  8 - PRIORITY ACTION WRITTEN Type: CPRA

• 4/2/2013 - 11 years ago

  10 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN

• 3/4/2014 - 10 years ago

  19 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 8/12/2013 - 11 years ago

  11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/12/2013 - 11 years ago

  12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/13/2013 - 11 years ago

  13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/5/2013 - 11 years ago

  14 - FINAL REFUSAL WRITTEN Type: CNFR

• 9/5/2013 - 11 years ago

  15 - FINAL REFUSAL E-MAILED Type: GNFR

• 9/5/2013 - 11 years ago

  16 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 3/4/2014 - 10 years ago

  17 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 3/4/2014 - 10 years ago

  18 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 3/4/2014 - 10 years ago

  20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 3/4/2014 - 10 years ago

  21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/5/2014 - 9 years ago

  29 - SOU EXTENSION 1 GRANTED Type: EX1G

• 3/15/2014 - 10 years ago

  22 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 4/2/2014 - 10 years ago

  23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 4/22/2014 - 10 years ago

  24 - PUBLISHED FOR OPPOSITION Type: PUBO

• 4/22/2014 - 10 years ago

  25 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/17/2014 - 10 years ago

  26 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 12/5/2014 - 9 years ago

  27 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 12/5/2014 - 9 years ago

  28 - SOU EXTENSION 1 FILED Type: EXT1

• 8/11/2015 - 9 years ago

  36 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA

• 9/15/2020 - 4 years ago

  38 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 9/14/2021 - 3 years ago

  39 - TEAS SECTION 8 & 15 RECEIVED Type: E815

• 12/9/2014 - 9 years ago

  30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 6/15/2015 - 9 years ago

  31 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 6/15/2015 - 9 years ago

  33 - USE AMENDMENT FILED Type: IUAF

• 7/17/2015 - 9 years ago

  34 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC

• 7/14/2015 - 9 years ago

  32 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 8/10/2015 - 9 years ago

  35 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR

• 9/15/2015 - 9 years ago

  37 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 12/14/2021 - 2 years ago

  40 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 12/15/2021 - 2 years ago

  42 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85

• 9/15/2024 - 2 months ago

  43 - COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Type: REM2

• 12/15/2021 - 2 years ago

  41 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15A